Colitis and colonic mucosal barrier dysfunction

Gut

Volumn 37, Issue 4, 1995, Pages 530-535

  Gardiner, K R ^a   Anderson, N H ^a   Rowlands, B J ^a   Barbul, A ^b  

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

acetic acid; endotoxaemia; ethanol; hapten; permeability

Indexed keywords

ACETIC ACID; ENDOTOXIN; HAPTEN; MACROGOL C 14; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLITIS; COLON; COMPLICATION; CONTROLLED STUDY; ENDOTOXEMIA; ENTERITIS; INTESTINE MUCOSA; NONHUMAN; PERMEABILITY; PERMEABILITY BARRIER; PRIORITY JOURNAL; RAT;

EID: 0028828335     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.37.4.530     Document Type: Article

References (47)

1. Keighley MRB, Arabi Y, Dimock F, Burdon DW, Allan RN, Alexander-Williams J. Influence of inflammatory bowel disease on the intestinal microflora. Gut 1978; 19: 1099-104.
2. Dickinson RJ, Varian SA, Axon ATR, Cooke EM. Increased incidence of faecal coliforms with in vitro adhesive and invasive properties in patients with ulcerative colitis. Gut 1980; 21: 787-92.
3. Eade MN, Brooke BN. Portal bacteraemia in cases of ulcerative colitis submitted to colectomy. Lancet 1969; i: 1008-9.
4. Ambrose NS, Johnson M, Burdon DW, Keighley MRB. Endogenous intraperitoneal contamination without emerotomy in surgery for Crohn's disease. Br J Surg 1983; 70: 301.
5. Ambrose NS, Johnson M, Burdon DW, Keighley MRB. Incidence of pathogenic bacteria from mesenteric lymph nodes and ileal serosa during Crohn's disease surgery. Br J Surg 1984; 71: 623-5.
6. Matthews N, Mayberry JF, Rhodes J, Neale L, Munro J, Wensinck F, et al. Agglutinins to bacteria in Crohn's disease. Gut 1980; 21: 376-80.
7. Aoki K. A study of endotoxaemia in ulcerative colitis and Crohn's disease. I. Clinical study. Acta Med Okayama 1978; 32: 147-58.
8. Colin R, Grancher T, Lemeland J-F, Hecketsweiler P, Galmiche JP, Le Grix A, et al. Recherche d'une endotoxinemie dans les entero-colities inflammatoires cryptogenetiques. Gastroenterol Clin Biol 1979; 3: 15-9.
9. Wellmann W, Fink PC, Benner F, Schmidt FW. Endotoxaemia in active Crohn's disease. Treatment with whole gut irrigation and 5-aminosalicylic acid. Gut 1986; 27: 814-20.
10. Gardiner KR, Barclay GR, McCaigue MD, Erwin PJ, Stephens S, Halliday MI, et al. The significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995; 36: 897-901.
11. Kruis W, Schussler P, Weinzierl M, Galanos C, Eisenburg J. Circulating lipid A antibodies despite absence of systemic endotoxemia in patients with Crohn's disease. Dig Dis Sci 1984; 29: 502-7.
12. Sartor RB, Cleland DR, Catalano CJ, Schwab JH. Serum antibody to bacterial cell wall peptidoglycan in inflammatory bowel disease patients. Gastroenterology 1985; 88: 1571A.
13. Liehr H. The limulus assay for endotoxaemia as applied in gastroenterology. In: E Cohen, ed. Biomedical applications of the horseshoe crab (Limulidae). New York: Liss 1979: 309-20.
14. Nolan JP. Endotoxin, reticuloendothelial function and liver injury. Hepatology 1981; 1: 458-65.
15. Magliulo E, Scevola D, Fumarola D. Limulus test in Escherichia coli enteritis. Lancet 1975; i: 407.
16. Brock-Utne JG, Gaffin SL. Endotoxins and anti-endotoxins (their relevance to the anaesthetist and the intensive care specialist). Anaesth Intensive Care 1989; 17: 49-55.
17. Kiss A, Ferenci P, Graninger W, Pamperl H, Potzi R, Meryn S. Endotoxaemia following colonoscopy. Endoscopy 1983; 15: 24-6.
18. Fossard DP, Kakkar VV. The Limulus test in experimental and clinical endotoxaemia. Br J Surg 1974; 61: 798-804.
19. Cuevas P, Fine J. Demonstration of a lethal endotoxemia in experimental occlusion of the superior mesenteric artery Surg Gynecol Obstet 1971; 133: 81-3.
20. Jenkins RT, Goodacre RL, Rooney PJ, Bienenstock J, Sivakumaran T, Walker WHC. Studies of intestinal permeability in inflammatory diseases using polyethylene glycol 400. Clin Biochem 1986; 19: 298-302.
21. Gardiner KR, Anderson NH, McCaigue MD, Erwin PJ, Halliday MI, Rowlands BJ. Adsorbents as anti-endotoxin agents in experimental colitis. Gut 1993; 34: 51-5.
22. Shorter RG, Huizenga KA, Spencer RJ. A working hypothesis for the etiology and pathogenesis of nonspecific inflammatory bowel disease. Am J Dig Dis 1972; 17: 1024-32.
23. Kirsner JB, Shorter RG. Recent developments in non-specific inflammatory bowel disease. N Engl J Med 1982; 306: 837-48.
24. Fordtran JS, Rector FC, Locklear TW, Ewton MF. Water and solute movement in the small intestine of patients with sprue. J Clin Invest 1967; 46: 287-98.
25. Berg RD, Garlington AW. Translocation of certain indigenous bacteria from the gastrointestinal tract to the mesenteric lymph nodes and other organs in a gnotobiotic mouse model. Infect Immun 1979; 23: 403-11.
26. Morris GP, Beck PL, Herridge MS, Depew WT, Szewczuk MR, Wallace JL. Hapten-induced model of chronic inflammation and ulceration in the rat colon Gastroenterology 1989; 96: 795-803.
27. Boughton-Smith NK, Wallace JL, Morris GP, Whittle BJR. The effect of anti-inflammatory drugs on eicosanoid formation in a chronic model of inflammatory bowel disease in the rat. Br J Pharmacol 1988; 94: 65-72.
28. Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacaro JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989; 97: 326-37.
29. Vilaseca J, Salas A, Guarner F, Rodríguez R, Martínez M, Malagelada J-R. Dietary fish oil reduces progression of chronic inflammatory lesions in a rat model of granulomatous colitis. Gut 1990; 31: 539-44.
30. Psaila JV, Myers B, Jones IR, Rhodes J. Effect of prostaglandin PGE2 in alcohol-induced ulceration in the rat colon. Digestion 1986; 35: 224-8.
31. MacPherson BR, Pfeiffer CJ. Experimental production of diffuse colitis in rats. Digestion 1978; 17: 135-50.
32. Aoki K. A study of endotoxemia in ulcerative colitis and Crohn's disease. II. Experimental study. Acta Med Okayama 1978; 32: 207-16.
33. Hotta T, Yoshida N, Yoshikawa T, Sugino S, Kondo M. Lipopolysaccharide-induced colitis in rabbits. Res Exp Med 1986; 186: 61-9.
34. Wessels BC, Gaffin SL. Anti-endotoxin immunotherapy for canine parvovirus endotoxaemia. J Small Anim Pract 1986; 27: 609-15.
35. Chadwick VS, Phillips SF, Hofman AF. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). I. Chemical analysis and biological properties of PEG 4000. Gastroenterology 1977; 73: 241-6.
36. Seidman EG, Hanson DG, Walker WA. Increased permeability to polyethylene glycol 4000 in rabbits with experimental colitis. Gastroenterology 1986; 90: 120-6.
37. Delahunty T, Recher L, Hollander D. Intestinal permeability changes in rodents: a possible mechanism for degraded carrageenan-induced colitis. Food Chem Toxicol 1987; 25: 113-8.
38. Chadwick VS, Gaginella TS, Carlson GL, Debongnie JC, Phillips SF, Hofmann AF. Effect of molecular structure on bile acid induced alterations in absorptive function, permeability, and morphology in perfused rabbit colon J Lab Clin Med 1979; 94: 661-74.
39. Gaginella TS, Chadwick VS, Debongie J-C, Lewis JC, Phillips SF. Perfusion of rabbit colon with ricinoleic acid: dose-related mucosal injury, fluid secretion, and increased permeability. Gastroenterology 1977; 73: 95-101.
40. 51Cr-EDTA in patients with gastrointestinal inflammatory disease. Am J Gastroenterol 1987; 82: 1159-64.
41. Casellas F, Aguade S, Soriano B, Accarino A, Molero J, Guarner L. Intestinal permeability to 99mTc DPTA in inflammatory bowel disease. Am J Gastroenterol 1986; 81: 767-70.
42. Gomes M de FA, Dunne J, Logan LH, Pounder RE. Non-invasive assessment of small intestinal damage in Crohn's disease and ulcerative colitis. Gut 1983; 24: 486A.
43. Gardiner KR, Erwin PJ, Anderson NH, Barr JG, Halliday MI, Rowlands BJ. Colonic bacteria and bacterial translocation in experimental colitis. Br J Surg 1993; 80: 512-6.
44. Rask-Madsen J, Hammersgaard EA, Knudson E. Rectal electrolyte transport and mucosal permeability in ulcerative colitis and Crohn's disease. J Lab Clin Med 1973; 81: 342-53.
45. O'Morain CA, Abelow AC, Chervu LR, Fleischner GM, Das KM. Chromium 51-ethylenediaminctetraacetate test: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med 1986; 108: 430-5.
46. Gardiner KR, Halliday MI, Lloyd F, Stephens S, Rowlands BJ. Circulating tumour necrosis factor in active inflammatory bowel disease. In: Faist E, Meakins J L, Schildberg F W, eds. Host defense dysfunction in trauma, shock and sepsis. Berlin: Springer-Verlag, 1993; 699-703
47. Mahida YR, Kurlak L, Hawkey CJ. High circulating concentrations of interleukin-6 (IL-6) in active Crohn's disease but not ulcerative colitis. Gut 1991; 32:: 1531-4.